Literature DB >> 25876458

Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Kalynda K Gonzales1,2, Yoland Smith1.   

Abstract

Striatal cholinergic interneurons (ChIs) are central for the processing and reinforcement of reward-related behaviors that are negatively affected in states of altered dopamine transmission, such as in Parkinson's disease or drug addiction. Nevertheless, the development of therapeutic interventions directed at ChIs has been hampered by our limited knowledge of the diverse anatomical and functional characteristics of these neurons in the dorsal and ventral striatum, combined with the lack of pharmacological tools to modulate specific cholinergic receptor subtypes. This review highlights some of the key morphological, synaptic, and functional differences between ChIs of different striatal regions and across species. It also provides an overview of our current knowledge of the cellular localization and function of cholinergic receptor subtypes. The future use of high-resolution anatomical and functional tools to study the synaptic microcircuitry of brain networks, along with the development of specific cholinergic receptor drugs, should help further elucidate the role of striatal ChIs and permit efficient targeting of cholinergic systems in various brain disorders, including Parkinson's disease and addiction.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  Parkinson's disease; accumbens; caudate nucleus; cocaine; drug addiction; putamen

Mesh:

Substances:

Year:  2015        PMID: 25876458      PMCID: PMC4564338          DOI: 10.1111/nyas.12762

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  615 in total

1.  Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining.

Authors:  A M Graybiel; C W Ragsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

2.  Differential changes in signal and background firing of accumbal neurons during cocaine self-administration.

Authors:  Laura L Peoples; Daniel Cavanaugh
Journal:  J Neurophysiol       Date:  2003-08       Impact factor: 2.714

3.  Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.

Authors:  Weilie Zhang; Masahisa Yamada; Jesus Gomeza; Anthony S Basile; Jürgen Wess
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

Review 4.  Putting a spin on the dorsal-ventral divide of the striatum.

Authors:  Pieter Voorn; Louk J M J Vanderschuren; Henk J Groenewegen; Trevor W Robbins; Cyriel M A Pennartz
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

5.  Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum.

Authors:  M Herkenham; C B Pert
Journal:  Nature       Date:  1981-06-04       Impact factor: 49.962

6.  D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum.

Authors:  C Le Moine; F Tison; B Bloch
Journal:  Neurosci Lett       Date:  1990-09-18       Impact factor: 3.046

7.  Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats.

Authors:  Agustin Zapata; Vicki L Minney; Toni S Shippenberg
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

8.  Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey.

Authors:  Darlene A Mitrano; Yoland Smith
Journal:  J Comp Neurol       Date:  2007-02-01       Impact factor: 3.215

9.  Putative cholinergic interneurons in the ventral and dorsal regions of the striatum have distinct roles in a two choice alternative association task.

Authors:  Orli Yarom; Dana Cohen
Journal:  Front Syst Neurosci       Date:  2011-05-31

10.  Acetylcholine, drug reward and substance use disorder treatment: intra- and interindividual striatal and accumbal neuron ensemble heterogeneity may explain apparent discrepant findings.

Authors:  Janine M Prast; Kai K Kummer; Constanze M Barwitz; Christian Humpel; Georg Dechant; Gerald Zernig
Journal:  Pharmacology       Date:  2012-09-25       Impact factor: 2.547

View more
  56 in total

1.  Letter to the Editor: A Novel Therapeutic for Opioid Use Disorder Targeting the Cholinergic System.

Authors:  Scott J Moeller; Anissa Abi-Dargham
Journal:  Am J Addict       Date:  2019-06-04

2.  Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.

Authors:  Sarah L Hawes; Armando G Salinas; David M Lovinger; Kim T Blackwell
Journal:  J Physiol       Date:  2017-05-26       Impact factor: 5.182

Review 3.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

4.  Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias.

Authors:  Tanuja Bordia; Xiomara A Perez; Jaime Heiss; Danhui Zhang; Maryka Quik
Journal:  Neurobiol Dis       Date:  2016-02-24       Impact factor: 5.996

Review 5.  Physiological roles of CNS muscarinic receptors gained from knockout mice.

Authors:  Morgane Thomsen; Gunnar Sørensen; Ditte Dencker
Journal:  Neuropharmacology       Date:  2017-09-11       Impact factor: 5.250

6.  PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer's disease.

Authors:  Tauqeerunnisa Syeda; Rachel M Foguth; Emily Llewellyn; Jason R Cannon
Journal:  Toxicology       Date:  2020-03-10       Impact factor: 4.221

Review 7.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

Review 8.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

9.  Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum.

Authors:  Nabil El Massri; Karen M Cullen; Sebastian Stefani; Cécile Moro; Napoleon Torres; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2018-01-29       Impact factor: 1.972

10.  Opposing roles for serotonin in cholinergic neurons of the ventral and dorsal striatum.

Authors:  Michael S Virk; Yotam Sagi; Lucian Medrihan; Jenny Leung; Michael G Kaplitt; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.